Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders

(2009) Thomas E. Delea et al.   CURRENT MEDICAL RESEARCH AND OPINION

Consensus statement on iron overload in myelodysplastic syndromes

(2008) John M. Bennett et al.   AMERICAN JOURNAL OF HEMATOLOGY

Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts

(2008) Cheng E. Chee et al.   AMERICAN JOURNAL OF HEMATOLOGY

International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes

(2008) Jelena M. Kao et al.   AMERICAN JOURNAL OF HEMATOLOGY

Further progress in CLL therapy

(2008) E. Montserrat   BLOOD

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

(2008) D. E. Rollison et al.   BLOOD

Platelet count is an IPSS-independent risk factor predicting survival in refractory anaemia with ringed sideroblasts

(2008) Shanique R. Palmer et al.   BRITISH JOURNAL OF HAEMATOLOGY

Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial

(2008) L. R. Zacharski et al.   JNCI-Journal of the National Cancer Institute

Myelodysplasia paranoia: Iron as the new radon

(2008) David P. Steensma   LEUKEMIA RESEARCH